Acura Pharmaceuticals Analysis
| ACURDelisted Stock | USD 0.05 0.00 0.00% |
Acura Pharmaceuticals is overvalued with Real Value of 0.0425 and Hype Value of 0.05. The main objective of Acura Pharmaceuticals otc analysis is to determine its intrinsic value, which is an estimate of what Acura Pharmaceuticals is worth, separate from its market price. There are two main types of Acura Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Acura Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Acura Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Acura Pharmaceuticals otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Acura Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Acura OTC Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Acura Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Acura |
Acura OTC Stock Analysis Notes
About 19.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 125.0. Acura Pharmaceuticals recorded a loss per share of 0.03. The entity had not issued any dividends in recent years. The firm had 1:5 split on the 28th of August 2015. Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people.The quote for Acura Pharmaceuticals is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Acura Pharmaceuticals please contact Robert Jones at 847 705 7709 or go to https://www.acurapharm.com.Acura Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more otcs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Acura Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Acura Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Acura Pharmaceuticals is not yet fully synchronised with the market data | |
| Acura Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Acura Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company currently holds 105 K in liabilities with Debt to Equity (D/E) ratio of 2.4, implying the company greatly relies on financing operations through barrowing. Acura Pharmaceuticals has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Acura Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Acura Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acura Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acura to invest in growth at high rates of return. When we think about Acura Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 3.57 M. Net Loss for the year was (1.21 M) with profit before overhead, payroll, taxes, and interest of 1.79 M. | |
| Acura Pharmaceuticals currently holds about 89 K in cash with (719 K) of positive cash flow from operations. | |
| Roughly 19.0% of Acura Pharmaceuticals shares are held by company insiders |
Acura Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.25 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Acura Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Acura Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Acura Profitablity
Acura Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Acura Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Acura Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Acura Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Acura Pharmaceuticals' profitability requires more research than a typical breakdown of Acura Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.51) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.49) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.49.
About Acura OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Acura Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Acura shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Acura Pharmaceuticals. By using and applying Acura OTC Stock analysis, traders can create a robust methodology for identifying Acura entry and exit points for their positions.
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Acura Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Acura OTC Stock
If you are still planning to invest in Acura Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acura Pharmaceuticals' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |